COST » Topics » Option/SAR Grants in Last Fiscal Year

This excerpt taken from the COST DEF 14A filed Dec 20, 2005.

Option/SAR Grants in Last Fiscal Year

 

Name


  

Number of

Securities

Underlying

Options/

SARs

Granted (#)(A)


  

% of Total

Options/

SARs

Granted to

Employees (B)


  

        Exercise or        

Base Price ($/Sh)


  

Expiration

Date


  

Potential Realizable

Value at Assumed

Annual Rates of

Stock Price

Appreciation for

Option Term (C)


               5% ($)

   10% ($)

James D. Sinegal    150,000    1.42    43.79    04/01/15    4,130,864    10,468,481
Jeffrey H. Brotman    150,000    1.42    43.79    04/01/15    4,130,864    10,468,481
Richard D. DiCerchio    90,000    .85    43.79    04/01/15    2,478,518    6,281,089
Richard A. Galanti    75,000    .71    43.79    04/01/15    2,065,432    5,234,241
W. Craig Jelinek    75,000    .71    43.79    04/01/15    2,065,432    5,234,241
Joseph P. Portera    75,000    .71    43.79    04/01/15    2,065,432    5,234,241

(A)   These stock options vest 20% per year for five years from the date of grant and expire ten years from the date of grant. The exercise price for these stock options equals the fair market value of the Common Stock on the date of grant.

 

(B)   The total number of stock options granted in fiscal 2005 by the Company was approximately 10,573,953 to approximately 2,520 persons.

 

(C)   These assumed rates of appreciation are provided in order to comply with requirements of the Securities and Exchange Commission and do not represent the Company’s expectation as to the actual rate of appreciation of the Common Stock. The actual value of the options will depend on the performance of the Common Stock and may be greater or less than the amounts shown.

 

8


"Option/SAR Grants in Last Fiscal Year" elsewhere:

J.C. Penney (JCP)
Barnes & Noble (BKS)
Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki